PMV Pharmaceuticals Inc [PMVP] stock is trading at $1.02, up 2.00%. An important factor to consider is whether the stock is rising or falling in short-term value. The PMVP shares have gain 17.24% over the last week, with a monthly amount drifted -20.31%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
PMV Pharmaceuticals Inc [NASDAQ: PMVP] stock has seen the most recent analyst activity on November 08, 2024, when Oppenheimer upgraded its rating to a Outperform but kept the price target unchanged to $6 for it. Previously, Craig Hallum started tracking the stock with Buy rating on May 13, 2024, and set its price target to $6. On April 12, 2024, Jefferies initiated with a Buy rating and assigned a price target of $5 on the stock. Ladenburg Thalmann started tracking the stock assigning a Buy rating and suggested a price target of $7 on December 27, 2023. Oppenheimer upgraded its rating to a Outperform but $30 remained the price target by the analyst firm on March 02, 2022. Goldman upgraded its rating to Buy for this stock on September 22, 2021, and upped its price target to $43. In a note dated August 19, 2021, Oppenheimer initiated an Perform rating.
PMV Pharmaceuticals Inc [PMVP] stock has fluctuated between $0.82 and $2.26 over the past year. Currently, Wall Street analysts expect the stock to reach $6 within the next 12 months. PMV Pharmaceuticals Inc [NASDAQ: PMVP] shares were valued at $1.02 at the most recent close of the market. An investor can expect a potential return of 488.24% based on the average PMVP price forecast.
Analyzing the PMVP fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.31, Equity is -0.29 and Total Capital is -0.48. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.9680 points at the first support level, and at 0.9160 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.0560, and for the 2nd resistance point, it is at 1.0920.
Ratios To Look Out For
For context, PMV Pharmaceuticals Inc’s Current Ratio is 12.22. On the other hand, the Quick Ratio is 12.22, and the Cash Ratio is 2.84.
Transactions by insiders
Recent insider trading involved Jalota Deepika, Chief Development Officer, that happened on Sep 11 ’24 when 7218.0 shares were sold. Chief Financial Officer, Carulli Michael completed a deal on Sep 11 ’24 to sell 2891.0 shares.
